Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Statins Help Lower Risk of Atherosclerosis by Reducing the Size of Arterial Plaques

By LabMedica International staff writers
Posted on 26 Dec 2011
Statins, a class of drugs that help reduce risk of atherosclerosis by lowering levels of low-density lipoproteins (LDL), also decrease the size of arterial plaques by stimulating macrophage emigration.

Investigators at New York University (NY, USA) worked with a novel mouse-transplant model of atherosclerosis regression in which aortic segments from diseased donors were placed into recipients with normal cholesterol levels. More...
With this model they had previously shown that the induction of a chemokine receptor CCR7(C-C chemokine receptor type 7)-dependent emigration process triggered the rapid loss of CD68+ cells (mainly macrophages) from arterial plaques.

In the current study, the investigators examined the effect of statins on macrophage emigration from plaques. They reported in the December 6, 2011, online edition the journal PLoS One that when mice that had been genetically engineered to lack the gene for apolipoprotein E were fed a western diet-fed while being treated with either atorvastatin or rosuvastatin they experienced a substantial reduction in the CD68+ cell content in the plaques despite continued hyperlipidemia. There was a significant increase in CCR7 mRNA in CD68+ cells from both atorvastatin and rosuvastatin treated mice associated with emigration of CD68+ cells from plaques. Mice that lacked both the gene for apolipoprotein E and the gene for CCR7 failed to display a reduction in CD68+ cell content upon statin treatment.

The results of this study indicate that statins, in addition to their traditionally considered effects on atherosclerosis by retarding plaque progression through lowering LDL-cholesterol, may also have additional clinical benefits by accelerating plaque regression through enhancing CCR7 expression and emigration of CD68+ macrophages. These beneficial effects would have been missed if changes in plaque size had been the sole criterion of success.

“Our experimental findings indicate that statins, in addition to lowering LDL cholesterol, have clinical benefits of accelerating plaque regression by a newly discovered mechanism,”said senior author Dr, Michael Garabedian, professor of microbiology and urology at New York University. “It is possible that these drugs could possibly be more beneficial to a wider population of patients potentially reducing the overall lifetime burden of plaque and the prevention of atherosclerosis.”

Related Links:

New York University


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researchers identified SARS-CoV-2 protein fragments within extracellular vesicles in the blood of long COVID patients (Photo courtesy of Shutterstock)

Blood Biomarker Test Could Confirm Long COVID Diagnosis

Long COVID remains a diagnostic challenge, with clinicians currently relying on a collection of symptoms that appear 12 weeks or more after SARS-CoV-2 infection. No blood tests or biomarkers currently... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Insights into sarcomatoid renal cell carcinoma point to broader use of common immunotherapies (Photo courtesy of Salgia NJ et al., Cancer Cell, 2025)

Novel Gene Signature Predicts Immunotherapy Response in Advanced Kidney Cancers

Sarcomatoid renal cell carcinoma (sRCC) is a rare, aggressive form of kidney cancer comprising about 5% of cases and is typically diagnosed at late stages. Resistant to most therapies, it has shown unusually... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.